Literature DB >> 11764326

Detection of antibodies to Borna disease virus in Turkish cats by using recombinant p40.

C R Helps1, N Turan, T Bilal, D A Harbour, H Yilmaz.   

Abstract

Recombinant p40 produced by baculovirus was used in an ELISA to screen samples of serum taken from 80 cats in Istanbul. The sera were also analysed for feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV). Antibodies to Borna disease virus- (BDV) p40 were detected in 34 (42-5 per cent) of the 80 cats. Seventy-three per cent of the sera which were positive for FIV and 26 per cent of the sera which were negative for FIV had antibodies to BDV. There was no difference in the percentage of sera which were positive for BDV between the cats that were positive or negative for FeLV. Three of the cats had neurological disease and two of these had antibodies to BDV. Six sera with low, medium or high optical densities (ODS) by ELISA were analysed by Western blotting. Only the sera with medium and high ODS reacted specifically with p40 at a dilution of 1 in 1,000.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764326     DOI: 10.1136/vr.149.21.647

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  3 in total

Review 1.  Borna disease virus.

Authors:  Mady Hornig; Thomas Briese; W Ian Lipkin
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

Review 2.  Infectious diseases of the central nervous system.

Authors:  Danièlle Gunn-Moore
Journal:  Vet Clin North Am Small Anim Pract       Date:  2005-01       Impact factor: 2.093

3.  A study on Borna disease virus infection in domestic cats in Japan.

Authors:  Azusa Someya; Ryoko Fukushima; Michiko Yoshida; Yasuyuki Tanahashi; Tangmunkhong Prapeuk; Reiko Iizuka; Hiroshi Hirami; Atsushi Matsuda; Shunichi Takahashi; Goro Kurita; Takashi Kimura; Misuzu Seo; Masayuki Funaba; Yoshii Nishino
Journal:  J Vet Med Sci       Date:  2014-05-08       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.